Intimation with regards to "Shelter Pharma" Secured Order from Taha Drugs & Chemicals Co. Ltd Pursuant to Regulatio 30 of SEBI(Listing Obligation and Disclosure Requirement) Regulation, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shelter Pharma Limited has secured a fixed-cost export order worth USD 138,075 (approximately ₹1.15 crore) from Taha Drugs & Chemicals Co. Ltd, an international client based in Sudan. The order is for nutraceutical capsules and tablets and is to be executed within 2 months from the date of intimation (May 5, 2025). The transaction is an arm's length deal with no related-party involvement, and the client's promoter group has no interest in Shelter Pharma. The company is a Gujarat-based pharmaceutical and nutraceutical manufacturer focused on health and wellness products.
This is a modest-sized international order that demonstrates the company's ability to win export business, but the order value is relatively small and its impact on overall revenue or stock price is likely limited. Positive for sentiment around export capabilities, but not a material catalyst.